Acetylsalicylic acid Recruiting Phase 4 Trials for Coronary Artery Disease / Nonvalvular Atrial Fibrillation Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT04006288Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
NCT03417388Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD